Archive for the 'How Things Begin' Category

How Things Begin (honey wine vinegar)

Tuesday, February 7th, 2012

At the recent Fancy Food Show in San Francisco, the most impressive product I encountered was a honey wine vinegar made by Slide Ridge Honey, a small family business in northern Utah. I interviewed the developer, Martin James, about how the business and product began.

How did your business begin? (more…)

The Legacy of Steve Jobs

Wednesday, December 28th, 2011

Sue Halpern has written the first interesting assessment of Steve Jobs I’ve seen, in the form of a book review of Isaacson’s biography. It happens to be very negative. She says little about his now-well-known bad treatment of coworkers, friends and family (“a bully, a dissembler, a cheapskate, a deadbeat dad, a manipulator”) and focusses on the effects of Apple Computer, which are obviously much greater.

She makes one very bad point. He should not call himself an artist, she argues:

There is no doubt that the products Steve Jobs brilliantly conceived of and oversaw at Apple were elegant and beautiful, but they were, in the end, products. Artists, typically, aim to put something of enduring beauty into the world; consumer electronics companies aim to sell a lot of gadgets, manufacturing desire for this year’s model in the hope that people will discard last year’s.

“In the end, products”? “Gadgets”? Are books gadgets? I cannot imagine a future without books. Nor one without cellphones and laptops. If they are lovely and work well, so much the better for all of us.  Moreover, cellphones and laptops, much more than other necessities (food, clothes, housing, transportation, medicine) help us express ourselves — our hidden inner selves — in so many ways. (Like art and books, but better.) Mark Fraunfelder made a similar point (obliquely).

“Products” and “gadgets” is Halpern’s conventional anti-consumerism. She goes on to make two equally conventional but much better points:

According to a study reported by Bloomberg News last January, Apple ranked at the very bottom of twenty-nine global tech firms “in terms of responsiveness and transparency to health and environmental concerns in China.” Yet walking into the Foxconn factory, where people routinely work six days a week, from early in the morning till late at night standing in enforced silence, Steve Jobs might have entered his biggest reality distortion field of all. “You go into this place and it’s a factory but, my gosh, they’ve got restaurants and movie theaters and hospitals and swimming pools,” he said after being queried by reporters about working conditions there shortly after a spate of suicides. “For a factory, it’s pretty nice.”

Apple had (and has) the power to improve working conditions at Foxconn. I completely agree: this was (and is) an enormous missed opportunity, for which Steve Jobs is completely responsible. No doubt he said that Apple products empower individuals (and they do) — well, how about empowering Foxconn workers?

Halpern’s final point is about recycling:

Next year will bring the iPhone 5, and a new MacBook, and more iPods and iMacs. What this means is that somewhere in the third world, poor people are picking through heaps of electronic waste in an effort to recover bits of gold and other metals and maybe make a dollar or two. Piled high and toxic, it is leaking poisons and carcinogens like lead, cadmium, and mercury that leach into their skin, the ground, the air, the water. Such may be the longest-lasting legacy of Steve Jobs’s art.

Yeah. Apple could (and can) lead the world in making their products easy to recycle. They haven’t. Entirely Steve Jobs’ fault. As Halpern says, this really matters.

Steve Jobs spent his working life (a) exploiting the commercial potential of new products (home computer, etc.) in large part by (b) caring obsessively, much more than others in his rarefied position, such as Bill Gates, about how they made him feel. Apple made products that Steve Jobs enjoyed. Fine. The problem is what Steve Jobs enjoyed. My take on him is a lot can be explained by (a) he cared little what others thought of him and (b) he lived in a tiny, uncomplicated intellectual world — as illustrated by his remarks about Foxconn and his Stanford graduation speech. Nabokov might say he had the emotional development of a child and the curiosity of an adult.

He left behind a company that reflects the shallowness of what he cared about. Those who take over Apple Computer are likely to be less shallow than he was — most people are. I predict the company will begin to care more about working conditions, ease of recycling, and other things beyond immediate user experience.

Evidence-Based Medicine Versus Innovation

Saturday, November 19th, 2011

In this interview, a doctor who does research on biofilms named Randall Wolcott makes the same point I made about Testing Treatments — that evidence-based medicine, as now practiced, suppresses innovation:

I take it you [meaning the interviewer] are familiar with evidence-based medicine? It’s the increasingly accepted approach for making clinical decisions about how to treat a patient. Basically, doctors are trained to make a decision based on the most current evidence derived from research. But what such thinking boils down to [in practice -- theory is different] is that I am supposed to do the same thing that has always been done – to treat my patient in the conventional manner – just because it’s become the most popular approach. However, when it comes to chronic wound biofilms, we are in the midst of a crisis – what has been done and is accepted as the standard treatment doesn’t work and doesn’t meet the needs of the patient.

Thus, evidence-based medicine totally regulates against innovation. Essentially doctors suffer if they step away from mainstream thinking. Sure, there are charlatans out there who are trying to sell us treatments that don’t work, but there are many good therapies that are not used because they are unconventional. It is only by considering new treatment options that we can progress.

Right on. He goes on to say that he is unwilling to do a double-blind clinical trial in which some patients do not receive his new therapy because “we know we’ve got the methods to save most of their limbs” from amputation.

Almost all scientific and intellectual history (and much serious journalism) is about how things begin. How ideas began and spread, how inventions are invented. If you write about Steve Jobs, for example, that’s your real subject. How things fail to begin — how good ideas are killed off — is at least as important, but much harder to write about. This is why Tyler Cowen’s The Great Stagnation is such an important book. It says nothing about the killing-off processes, but at least it describes the stagnation they have caused. Stagnation should scare us. As Jane Jacobs often said, if it lasts long enough, it causes collapse.

Thanks to Heidi.

Testing Treatments: The Authors Respond

Saturday, November 12th, 2011

In a previous post I criticized the book Testing Treatments. Two of the authors, Paul Glasziou and Iain Chalmers, have responded. I have replied to their response. They did not respond to the main point of my post, which is that the preferences and values of their book — called evidence-based medicine — hinder innovation.

Sure, care about evidence. Of course. But don’t be an evidence snob.

Testing Treatments: Nine Questions For the Authors

Sunday, November 6th, 2011

From this comment (thanks, Elizabeth Molin) I learned of a British book called Testing Treatments (pdf), whose second edition has just come out. Its goal is to make readers more sophisticated consumers of medical research. To help them distinguish “good” science from “bad” science. Ben Goldacre, the Bad Science columnist, fulsomely praises it (“I genuinely, truly, cannot recommend this awesome book highly enough for its clarity, depth, and humanity”). He wrote a foreword. The main text is by Imogen Evans (medical journalist), Hazel Thornton (writer),  Iain Chalmers (medical researcher), and Paul Glaziou (medical researcher, editor of Journal of Evidence-Based Medicine).

To me, as I’ve said, medical research is almost entirely bad. Almost all medical researchers accept two remarkable rules: (a) first, let them get sick and (b) no cheap remedies. These rules severely limit what is studied. In terms of useful progress, the price of these limits has been enormous: near total enfeeblement. For many years the Nobel Prize in Medicine has documented the continuing failure of medical researchers all over the world to make significant progress on all major health problems, including depression, heart disease, obesity, cancer, diabetes, stroke, and so on. It is consistent with their level of understanding that some people associated with medicine would write a book about how to do something (good science) the whole field manifestly can’t do. Testing Treatments isn’t just a fat person writing a book about how to lose weight, it’s the author failing to notice he’s fat. (more…)